Results 21 to 30 of about 1,126,107 (137)

A superconducting CW-LINAC for heavy ion acceleration at GSI

open access: yesEPJ Web of Conferences, 2017
Recently the Universal Linear Accelerator (UNILAC) serves as a powerful high duty factor (25%) heavy ion beam accelerator for the ambitious experiment program at GSI.
Barth Winfried   +7 more
doaj   +1 more source

CLDN18.2 expression and its impact on prognosis and the immune microenvironment in gastric cancer

open access: yesBMC Gastroenterology, 2023
Background The investigational use of zolbetuximab (IMAB362), a groundbreaking monoclonal antibody medication targeting claudin 18.2 (CLDN18.2), for treatment of advanced gastrointestinal cancers is currently underway.
Canming Wang   +7 more
doaj   +1 more source

sj-docx-1-him-10.1177_18333583231197756 – Supplemental material for A documentary analysis of Victorian Government health information assets’ websites to identify availability of documentation for data sharing and reuse in Australia

open access: yes, 2023
Supplemental material, sj-docx-1-him-10.1177_18333583231197756 for A documentary analysis of Victorian Government health information assets’ websites to identify availability of documentation for data sharing and reuse in Australia by Merilyn F.
Monique F Kilkenny (5883113)   +3 more
core   +1 more source

sj-xlsx-1-him-10.1177_18333583221089915 – Supplemental Material for Use of linked patient data to assess the effect of Long-COVID on system-wide healthcare utilisation

open access: yes, 2022
Supplemental Material, sj-xlsx-1-him-10.1177_18333583221089915 for Use of linked patient data to assess the effect of Long-COVID on system-wide healthcare utilisation by Ben J Murch, Sarah E Hollier, Charlie Kenward and Richard M Wood in Health ...
Sarah E Hollier (12649237)   +3 more
core   +1 more source

Alternative splicing in ovarian cancer

open access: yesCell Communication and Signaling
Ovarian cancer is the second leading cause of gynecologic cancer death worldwide, with only 20% of cases detected early due to its elusive nature, limiting successful treatment. Most deaths occur from the disease progressing to advanced stages.
Liwei Wei   +6 more
doaj   +1 more source

Comparison of the long-term impact of laparoscopy and open surgery on the prognosis of patients with locally advanced gastric cancer

open access: yesScientific Reports
Currently, the choice of surgical procedure for patients with locally advanced gastric cancer remains controversial. This study aimed to investigate the difference in prognosis between laparoscopy and open surgery in patients with locally advanced ...
Ming-cong Deng   +19 more
doaj   +1 more source

HIM

open access: yesEnletawa Journal, 2022
A poem by Jhonatan Vásquez-Guarnizo.
Jhonatan Vásquez-Guarnizo
doaj   +1 more source

Rational and design of prophylactic cranial irradiation (PCI) and brain MRI surveillance versus brain MRI surveillance alone in patients with limited-stage small cell lung cancer achieving complete remission (CR) of tumor after chemoradiotherapy: a multicenter prospective randomized study

open access: yesBMC Cancer
Background Prophylactic cranial irradiation (PCI) is part of standard care in limited-stage small cell lung cancer (SCLC) at present. As evidence from retrospective studies increases, the benefits of PCI for limited-stage SCLC are being challenged ...
Mengyuan Chen   +8 more
doaj   +1 more source

AR-CDT NET: a deep deformable convolutional network for gut microbiome-based disease classification

open access: yesBMC Bioinformatics
Advances in metagenomic sequencing have increasingly implicated gut microbiome dysbiosis in numerous complex diseases, yet its application for precise differential diagnosis remains a major challenge.
Jiaye Li   +5 more
doaj   +1 more source

Sintilimab plus anlotinib as second‐ or third‐line therapy in metastatic non‐small cell lung cancer with uncommon epidermal growth factor receptor mutations: A prospective, single‐arm, phase II trial

open access: yesCancer Medicine, 2023
Background Patients with non‐small‐cell lung cancer (NSCLC) and uncommon EGFR alterations typically have worse treatment outcomes than patients with classically EGFR‐mutated NSCLC.
Kaiyan Chen   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy